| Literature DB >> 36003743 |
Amer Harky1,2,3, Sabrina Mason2, Ahmed Othman1, Matthew Shaw1,3, Omar Nawaytou1, Deborah Harrington1, Manoj Kuduvalli1, Mark Field1,2,3.
Abstract
Objective: We sought to report our experience of repairing acute type A aortic dissection (ATAAD) over 21 years during in-hours versus out-of-hours before and after the establishment of specialized aortic service and rota.Entities:
Keywords: ATAAD, acute type A aortic dissection; CVA, cerebrovascular accident; ICU, intensive care unit; IRAD, International Registry of Acute Aortic Dissections; SAR, specialized aortic rota; TIA, transient ischemic attack; aorta; dissection; outcomes; timing of surgery
Year: 2021 PMID: 36003743 PMCID: PMC9390141 DOI: 10.1016/j.xjon.2021.04.017
Source DB: PubMed Journal: JTCVS Open ISSN: 2666-2736
Figure 1Reported outcomes for patients who underwent repair of acute type A aortic dissection during in hours (8:00 am-7:59 pm) versus out of hours (8:00 pm-7:59 am) during prerota times (October 1998-September 2007) and within the specialized aortic rota times (between October 2007 and December 2019). There was no difference in stroke and 30-day mortality rate between in-hours and out-of-hours surgery.
Figure 2Case distribution between prerota times and specialized aortic rota.
Patient demographic characteristics for prerota and specialized aortic rota time periods, stratified by operative time
| Characteristic | Pre-rota time period | Specialized aortic rota time period | ||||
|---|---|---|---|---|---|---|
| In hours (n = 43) | Out of hours (n = 37) | In hours (n = 110) | Out of hours (n = 96) | |||
| Age at operation (y) | 63 (53-69) | 62 (53-67) | .66 | 63 (48-72) | 60 (52-69) | .54 |
| Female | 9 (20.9) | 8 (21.6) | .94 | 33 (30.0) | 40 (41.7) | .08 |
| Body mass index | 26.4 (24.1-28.2) | 27.5 (24.7-29.4) | .22 | 27.8 (24.5-32.0) | 27.5 (24.0-31.0) | .43 |
| Angina class IV | 4 (9.3) | 4 (10.8) | >.99 | 11 (10.0) | 4 (4.2) | .11 |
| Previous myocardial infarction | 2 (4.7) | 2 (5.4) | >.99 | 9 (8.2) | 3 (3.1) | .12 |
| Myocardial infarction within the last 90 d | 1 (2.3) | 1 (2.7) | >.99 | 8 (7.3) | 2 (2.1) | .11 |
| New York Heart Association functional class ≥ III | 7 (16.3) | 5 (13.5) | .73 | 12 (10.9) | 10 (10.4) | .91 |
| Current smoker | 10 (23.3) | 13 (35.1) | .24 | 20 (18.2) | 22 (22.9) | .40 |
| Diabetes | 1 (2.3) | 0 (0) | >.99 | 7 (6.4) | 4 (4.2) | .48 |
| Respiratory disease | 10 (23.3) | 6 (16.2) | .43 | 18 (16.4) | 11 (11.5) | .31 |
| Hypercholesterolemia | 11 (25.6) | 5 (13.5) | .18 | 32 (29.1) | 19 (19.8) | .12 |
| Hypertension | 30 (69.8) | 26 (70.3) | .96 | 70 (63.6) | 48 (50.0) | .048 |
| Previous stroke | 4 (9.3) | 4 (10.8) | >.99 | 6 (5.5) | 7 (7.3) | .59 |
| Peripheral vascular disease | 4 (9.3) | 4 (10.8) | >.99 | 8 (7.3) | 5 (5.2) | .54 |
| Renal dysfunction | 3 (7.0) | 6 (16.2) | .29 | 24 (21.8) | 17 (17.7) | .46 |
| Left ventricular ejection fraction 30%-50% | 6 (14.0) | 3 (8.1) | .49 | 16 (14.6) | 11 (11.5) | .51 |
| Left ventricular ejection fraction <30% | 2 (4.7) | 1 (2.7) | >.99 | 5 (4.6) | 2 (2.1) | .45 |
| Ischemic heart disease | 6 (14.0) | 1 (2.7) | .12 | 11 (10.0) | 4 (4.2) | .11 |
| Previous cardiac surgery | 3 (7.0) | 1 (2.7) | .62 | 8 (7.3) | 1 (1.0) | .04 |
| Malperfusion | 0 (0) | 0 (0) | – | 2 (1.2) | 8 (8.3) | .05 |
| Time from presentation to surgery (min) | 585 (190-1298) | 185 (130-301) | <.001 | 592 (200-1244) | 233 (167-339) | <.001 |
Values are presented as median (range) or n (%).
Respiratory disease was defined as patients having forced expiratory volume in 1 second <75%, asthma, emphysema, chronic obstructive airway disease, or being on respiratory medications.
Renal dysfunction was defined as patients with a functioning renal transplant and patients with acute or chronic renal failure or insufficiency.
Patient demographic characteristics for prerota and specialized aortic rota time periods
| Characteristic | Prerota (n = 80) | Postrota (n = 206) | |
|---|---|---|---|
| Age at operation (y) | 63 (53-67) | 61 (51-72) | .53 |
| Female | 17 (21.3) | 73 (35.4) | .02 |
| BMI | 27.0 (24.3-29.3) | 27.7 (24.2-31.2) | .12 |
| Angina class IV | 8 (10.0) | 15 (7.3) | .45 |
| Previous myocardial infarction | 4 (5.0) | 12 (5.8) | >.99 |
| Myocardial infarction within the last 90 d | 2 (2.5) | 10 (4.9) | .52 |
| NYHA class ≥ III | 12 (15.0) | 22 (10.7) | .31 |
| Current smoker | 23 (28.8) | 42 (20.4) | .13 |
| Diabetes | 1 (1.3) | 11 (5.3) | .19 |
| Respiratory disease | 16 (20.0) | 29 (14.1) | .22 |
| Hypercholesterolemia | 16 (20.0) | 51 (24.8) | .39 |
| Hypertension | 56 (70.0) | 118 (57.3) | .048 |
| Previous stroke | 8 (10.0) | 13 (6.3) | .28 |
| Peripheral vascular disease | 8 (10.0) | 13 (6.3) | .28 |
| Renal dysfunction | 9 (11.3) | 41 (19.9) | .08 |
| Left ventricular ejection fraction 30%-50% | 9 (11.3) | 27 (13.1) | .67 |
| Left ventricular ejection fraction <30% | 3 (3.8) | 7 (3.4) | >.99 |
| Ischemic heart disease | 7 (8.8) | 15 (7.3) | .68 |
| Previous cardiac surgery | 4 (5.0) | 9 (4.4) | .76 |
Values are presented as median (range) or n (%). BMI, Body mass index; NYHA, New York Heart Association.
Respiratory disease was defined as patients having forced expiratory volume in 1 second <75%, asthma, emphysema, chronic obstructive airway disease, or being on respiratory medications.
Renal dysfunction was defined as patients with a functioning renal transplant and patients with acute or chronic renal failure or insufficiency.
Intraoperative variables for prerota and specialized aortic rota time periods, stratified by operative time
| Variable | Prerota time period | Specialized aortic rota time period | ||||
|---|---|---|---|---|---|---|
| In hours (n = 43) | Out of hours (n = 37) | In hours (n = 110) | Out of hours (n = 96) | |||
| Aortic root | 9 (20.9) | 9 (24.3) | .72 | 36 (32.7) | 46 (47.9) | .03 |
| Frozen elephant trunk | 0 (0) | 0 (0) | na | 18 (16.4) | 8 (8.3) | .08 |
| With or without total arch | 16 (37.2) | 12 (32.4) | .66 | 27 (24.6) | 22 (22.9) | .78 |
| CPB time (min) | 279 (220-355) | 318 (261-357) | .17 | 341 (283-418) | 349 (285-415) | .69 |
| AXC time (min) | 141 (112-182) | 152 (126-204) | .31 | 199 (148-262) | 205 (154-251) | .84 |
| Circulatory arrest time | 36 (28-56) | 45 (31-67) | .31 | 52 (42-74) | 46 (35-59) | .02 |
Values are presented as median (range) or n (%). na, Not available; CPB, cardiopulmonary bypass; AXC, aortic crossclamp.
Postoperative outcomes for prerota and specialized aortic rota time periods, stratified by operative time
| Outcome | Prerota time period | Specialized aortic rota time period | ||||
|---|---|---|---|---|---|---|
| In hours (n = 43) | Out of hours (n = 37) | In hours (n = 110) | Out of hours (n = 96) | |||
| Composite outcome | 23 (53.5) | 20 (54.1) | .96 | 43 (39.1) | 38 (39.6) | .94 |
| 30-d mortality | 10 (23.3) | 12 (32.4) | .36 | 13 (11.6) | 11 (11.5) | .94 |
| CVA | 8 (18.6) | 5 (13.5) | .54 | 14 (12.7) | 15 (15.6) | .55 |
| TIA | 0 (0) | 1 (2.7) | .46 | 1 (0.9) | 3 (3.1) | .34 |
| Reoperation for bleeding/tamponade | 6 (14.0) | 4 (10.8) | .75 | 18 (16.4) | 9 (9.4) | .14 |
| New hemofiltration/renal failure | 10 (23.3) | 11 (29.7) | .51 | 17 (15.5) | 17 (17.7) | .66 |
| ICU stay (d) | 4 (2-7) | 4 (1-7) | .67 | 9 (4-15) | 7 (5-21) | .95 |
| Total hospital stay (d) | 15 (8-24) | 11 (6-18) | .22 | 16 (10-29) | 14 (9-28) | .55 |
Values are presented as median (range) or n (%). CVA, Cerebrovascular accident; TIA, transient ischemic attack; ICU, intensive care unit.
Composite outcome, defined as patients experiencing any of the following: mortality at 30-days, CVA, TIA, new heart failure/renal failure, or reoperation for bleeding.
Logistic regression results for acute type A aortic dissection population, with the composite outcome measure as the dependent variable
| Covariate | Odds ratio (95% confidence interval) | |
|---|---|---|
| Out-of-hours surgery | 1.20 (0.74-1.97) | .46 |
| Female | 0.34 (0.20-0.60) | <.001 |
| Respiratory disease | 2.31 (1.17-4.56) | .02 |
| Left ventricular ejection fraction 30%-50% | 2.25 (1.07-4.74) | .03 |
Figure E1Panel chart showing increase in activity of acute type A aortic dissection repair and reduction in 30-day mortality.